99 related articles for article (PubMed ID: 19101395)
1. Kidney injury molecule 1: in search of biomarkers of chronic tubulointerstitial damage and disease progression.
Perico N; Cattaneo D; Remuzzi G
Am J Kidney Dis; 2009 Jan; 53(1):1-4. PubMed ID: 19101395
[No Abstract] [Full Text] [Related]
2. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of tubulointerstitial injury by new biomarkers].
Mori K; Mukoyama M; Kasahara M; Nakao K
Nihon Jinzo Gakkai Shi; 2011; 53(4):596-9. PubMed ID: 21688478
[No Abstract] [Full Text] [Related]
4. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury.
Bonventre JV
Scand J Clin Lab Invest Suppl; 2008; 241():78-83. PubMed ID: 18569971
[TBL] [Abstract][Full Text] [Related]
5. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
6. Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective nested case-control study.
Liang XL; Liu SX; Chen YH; Yan LJ; Li H; Xuan HJ; Liang YZ; Shi W
Biomarkers; 2010 Jun; 15(4):332-9. PubMed ID: 20233133
[TBL] [Abstract][Full Text] [Related]
7. [Acute kidney injury].
Doi K; Negishi K; Noiri E
Nihon Jinzo Gakkai Shi; 2011; 53(1):18-24. PubMed ID: 21370573
[No Abstract] [Full Text] [Related]
8. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation.
Fanelli C; Fernandes BH; Machado FG; Okabe C; Malheiros DM; Fujihara CK; Zatz R
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F580-7. PubMed ID: 21653629
[TBL] [Abstract][Full Text] [Related]
9. Kidney injury molecule-1 in renal disease.
Waanders F; van Timmeren MM; Stegeman CA; Bakker SJ; van Goor H
J Pathol; 2010 Jan; 220(1):7-16. PubMed ID: 19921716
[TBL] [Abstract][Full Text] [Related]
10. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
11. Urinary tubular biomarkers of kidney damage: potential value in clinical practice.
Waanders F; Navis G; van Goor H
Am J Kidney Dis; 2010 May; 55(5):813-6. PubMed ID: 20438985
[No Abstract] [Full Text] [Related]
12. [Proteinuria (in adults and children). Diagnostic orientation].
Soto B; Niaudet P
Rev Prat; 1997 Oct; 47(15):1717-22. PubMed ID: 9406520
[No Abstract] [Full Text] [Related]
13. [ Urinary sedimentation in the diagnosis of renal diseases].
Piccoli G; Rotunno M
G Clin Med; 1988 Oct; 69(10):595-9. PubMed ID: 3229609
[No Abstract] [Full Text] [Related]
14. Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury.
Huo W; Zhang K; Nie Z; Li Q; Jin F
Transplant Rev (Orlando); 2010 Jul; 24(3):143-6. PubMed ID: 20447817
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across species.
Patel-Chamberlin M; Wang Y; Satirapoj B; Phillips LM; Nast CC; Dai T; Watkins RA; Wu X; Natarajan R; Leng A; Ulanday K; Hirschberg RR; Lapage J; Nam EJ; Haq T; Adler SG
Kidney Int; 2011 May; 79(10):1138-48. PubMed ID: 21389974
[TBL] [Abstract][Full Text] [Related]
16. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model.
Fujihara CK; Malheiros DM; Zatz R
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1810-8. PubMed ID: 17344184
[TBL] [Abstract][Full Text] [Related]
17. Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension.
Fujisaki K; Tsuruya K; Nakano T; Taniguchi M; Higashi H; Katafuchi R; Kanai H; Nakayama M; Hirakata H; Kitazono T;
Hypertens Res; 2014 Nov; 37(11):993-8. PubMed ID: 24965167
[TBL] [Abstract][Full Text] [Related]
18. Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan.
Mihailovic-Stanojevic N; Jovovic D; Miloradovic Z; Grujic-Milanovic J; Jerkic M; Markovic-Lipkovski J
Nephrol Dial Transplant; 2009 Apr; 24(4):1142-50. PubMed ID: 18987260
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of urine from male dogs during early stages of tubulointerstitial injury in a canine model of progressive glomerular disease.
Nabity MB; Lees GE; Dangott LJ; Cianciolo R; Suchodolski JS; Steiner JM
Vet Clin Pathol; 2011 Jun; 40(2):222-36. PubMed ID: 21446987
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
Tanaka H; Suzuki K; Nakahata T; Tsugawa K; Konno Y; Tsuruga K; Ito E; Waga S
Pediatr Int; 2004 Oct; 46(5):576-9. PubMed ID: 15491387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
